Stella Diagnostics (Stella Diagnostics) EBITDA Margin % : 0.00% (As of Sep. 2023)

View and export this data going back to 2021. Start your Free Trial

What is Stella Diagnostics EBITDA Margin %?

EBITDA Margin % is calculated as EBITDA divided by its Revenue. Stella Diagnostics's EBITDA for the three months ended in Sep. 2023 was $-0.78 Mil. Stella Diagnostics's Revenue for the three months ended in Sep. 2023 was $0.00 Mil. Therefore, Stella Diagnostics's EBITDA margin for the quarter that ended in Sep. 2023 was 0.00%.

Stella Diagnostics EBITDA Margin % Historical Data

The historical data trend for Stella Diagnostics's EBITDA Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Stella Diagnostics EBITDA Margin % Chart

Stella Diagnostics Annual Data

Trend

EBITDA Margin %

Stella Diagnostics Quarterly Data
	Sep22	Sep23
EBITDA Margin %	-	-

Competitive Comparison of Stella Diagnostics's EBITDA Margin %

For the Diagnostics & Research subindustry, Stella Diagnostics's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Stella Diagnostics's EBITDA Margin % Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Stella Diagnostics's EBITDA Margin % distribution charts can be found below:

* The bar in red indicates where Stella Diagnostics's EBITDA Margin % falls into.

Stella Diagnostics EBITDA Margin % Calculation

EBITDA margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent.

Stella Diagnostics's EBITDA Margin % for the fiscal year that ended in . 20 is calculated as

EBITDA Margin %	=	EBITDA (A: . 20 )	/	Revenue (A: . 20 )
	=		/
	=	%

Stella Diagnostics's EBITDA Margin % for the quarter that ended in Sep. 2023 is calculated as

EBITDA Margin %	=	EBITDA (Q: Sep. 2023 )	/	Revenue (Q: Sep. 2023 )
	=	-0.777	/	0
	=	%

Stella Diagnostics (OTCPK:SLDX) EBITDA Margin % Explanation

EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.

Stella Diagnostics EBITDA Margin % Related Terms

Thank you for viewing the detailed overview of Stella Diagnostics's EBITDA Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

Stella Diagnostics (Stella Diagnostics) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Stella Diagnostics Inc (OTCPK:SLDX) » Definitions » EBITDA Margin %

Comparable Companies

Traded in Other Exchanges

N/A

Address

50 West Broadway, Suite 300, Salt Lake City, UT, USA, 84104

Website

https://www.stelladx.com

Stella Diagnostics Inc is a molecular diagnostics-based organization focused on improving patient management strategies for people living with severe esophageal disease. It is developing first-line diagnostic tools that provide superior molecular information for providers as compared to the current standard screening protocols.